文献速递骨肿瘤

新型列线图辅助预测脊索瘤患者复发与生存:中国大陆回顾性多中心研究

Novel Nomograms as Aids for Predicting Recurrence and Survival in Chordoma Patients: A Retrospective Multicenter Study in mainland China.
PubMed 文献 · Spine (Phila Pa 1976) · 2021-01-01

该回顾性多中心研究纳入中国大陆四家医疗中心2015年1月前治疗的341例脊索瘤患者,其中276例有完整预后变量数据,中位随访57.5个月(范围1-325个月)。研究通过Lasso回归和Cox比例风险回归识别局部无复发生存(LRFS)和总生存(OS)的预测因素,并构建列线图,LRFS和OS列线图的C指数分别为0.79和0.76,5年AUC分别为0.868和0.786。

要点

  • 179例(64.9%)患者出现复发,122例(44.2%)患者全因死亡,中位随访57.5个月(范围1-325个月)。
  • 复发相关因素包括肿瘤大小、肿瘤位置、组织学亚型和切除方式。
  • 死亡相关因素包括肿瘤大小、肿瘤位置、切除方式、并发症和术后复发。

核心结论

  • 基于多中心脊索瘤病例系列及相对较长随访,作者提出两个列线图,基于复发和死亡相关因素预测预后,这些发现可参考用于临床决策过程并为风险分层提供额外预后信息。

研究设计与样本

  • 回顾性数据分析,纳入中国大陆四家医疗中心2015年1月前治疗的脊索瘤患者,共识别341例患者,其中276例有完整预后变量数据。
  • 采用Lasso回归和Cox比例风险回归模型识别局部无复发生存(LRFS)和总生存(OS)的预测因素,并开发列线图。
  • 通过C指数、校准曲线和受试者工作特征曲线(ROC)分别评估列线图的区分度、校准度和准确性。
  • 证据等级为4级。

主要发现

  • 179例(64.9%)患者出现复发,122例(44.2%)患者全因死亡,中位随访57.5个月(范围1-325个月)。
  • 复发相关因素为肿瘤大小、肿瘤位置、组织学亚型和切除方式。
  • 死亡相关因素为肿瘤大小、肿瘤位置、切除方式、并发症和术后复发。
  • LRFS和OS列线图显示良好校准度和区分能力,C指数分别为0.79和0.76。
  • ROC提示预测能力尚可,5年AUC值分别为0.868和0.786。

关键数值与推荐

  • LRFS列线图的C指数为0.79,OS列线图的C指数为0.76。
  • LRFS列线图的5年AUC值为0.868,OS列线图的5年AUC值为0.786。
  • 复发相关因素:肿瘤大小、肿瘤位置、组织学亚型、切除方式。
  • 死亡相关因素:肿瘤大小、肿瘤位置、切除方式、并发症、术后复发。

临床怎么用

  • 作者认为这些发现可参考用于临床决策过程,并为风险分层提供额外预后信息。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: A retrospective data analysis was performed. OBJECTIVE: The aim of this study is to explore the significant prognostic factors and propose new nomograms to facilitate clinical decision-making. SUMMARY OF BACKGROUND DATA: Chordoma is a rare bone tumor. The clinical features and optimal therapeutic strategies are still uncertain. METHODS: Chordoma patients treated in four medical centers of mainland China before January 2015 were included. The predictors for local relapse-free survival (LRFS) and overall survival (OS) were identified by the Lasso regression and Cox proportional hazards regression model. Then the nomograms were developed. Their discrimination, calibration, and accuracy were evaluated by the C-index, calibration curve, and receiver operating characteristic curve (ROC), respectively. RESULTS: A total of 341 patients were identified and full prognostic variable data were available for 276 patients. A total of 179 patients (64.9%) experienced recurrence and 122 patients (44.2%) died of all causes with a median follow-up time of 57.5 (range, 1-325) months. We identified recurrence-relevant factors of tumor size, tumor location, histology subtype and resection method, and death-relevant factors of tumor size, tumor location, resection method, complication, and postoperative recurrence. The constructed LRFS and OS nomograms showed good calibration and discriminative ability (C index 0.79 and 0.76, respectively). The ROCs suggested decent prediction ability with the 5-year area under curve (AUC) value of 0.868 and 0.786, respectively. CONCLUSION: Based on the multicenter case series of chordoma with a relative long follow-up, we proposed two nomograms to predict the prognosis on the basis of recurrence- and death-relevant factors. These findings could be referenced in the clinical decision-making process and provide additional prognostic information for risk stratification. LEVEL OF EVIDENCE: 4.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Meng T, Huang R, Hu P, et al. Novel Nomograms as Aids for Predicting Recurrence and Survival in Chordoma Patients: A Retrospective Multicenter Study in mainland China. Spine (Phila Pa 1976). 2021. PMID: 32991511. doi:10.1097/BRS.0000000000003716

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。